The immunohistochemistry result of subcutaneous tumor indicated that knockdown CLSPN significantly down regulated CCNA2, CCNB1, CDK1, CDK2 and Ki67 expression (Fig. 10D). This evidence concerns the gene MKI67 and neoplasm.